Literature DB >> 20668026

Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice.

Richard S Lee1, Kellie L K Tamashiro, Xiaoju Yang, Ryan H Purcell, Amelia Harvey, Virginia L Willour, Yuqing Huo, Michael Rongione, Gary S Wand, James B Potash.   

Abstract

There is evidence for hypercortisolemia playing a role in the generation of psychiatric symptoms and for epigenetic variation within hypothalamic-pituitary-adrenal (HPA) axis genes mediating behavioral changes. We tested the hypothesis that expression changes would be induced in Fkbp5 and other HPA axis genes by chronic exposure to corticosterone and that these changes would occur through the epigenetic mechanism of loss or gain of DNA methylation (DNAm). We administered corticosterone (CORT) to C57BL/6J mice via their drinking water for 4 wk and tested for behavioral and physiological changes and changes in gene expression levels using RNA extracted from hippocampus, hypothalamus, and blood for the following HPA genes: Fkbp5, Nr3c1, Hsp90, Crh, and Crhr1. The CORT mice exhibited anxiety-like behavior in the elevated plus maze test. Chronic exposure to CORT also caused a significant decrease in the hippocampal and blood mRNA levels of Nr3c1 and a decrease in Hsp90 in blood and caused an increase in Fkbp5 for all tissues. Differences were seen in Fkbp5 methylation in hippocampus and hypothalamus. To isolate a single-cell type, we followed up with an HT-22 mouse hippocampal neuronal cell line exposed to CORT. After 7 d, we observed a 2.4-fold increase in Fkbp5 expression and a decrease in DNAm. In the CORT-treated mice, we also observed changes in blood DNAm in Fkbp5. Our results suggest DNAm plays a role in mediating effects of glucocorticoid exposure on Fkbp5 function, with potential consequences for behavior.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668026      PMCID: PMC2940504          DOI: 10.1210/en.2010-0225

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  46 in total

1.  Comprehensive high-throughput arrays for relative methylation (CHARM).

Authors:  Rafael A Irizarry; Christine Ladd-Acosta; Benilton Carvalho; Hao Wu; Sheri A Brandenburg; Jeffrey A Jeddeloh; Bo Wen; Andrew P Feinberg
Journal:  Genome Res       Date:  2008-03-03       Impact factor: 9.043

2.  Quantitative transcriptional neuroanatomy of the rat hippocampus: evidence for wide-ranging, pathway-specific heterogeneity among three principal cell layers.

Authors:  James G Greene; Karin Borges; Raymond Dingledine
Journal:  Hippocampus       Date:  2009-03       Impact factor: 3.899

3.  Large-scale analysis of glucocorticoid target genes in rat hypothalamus.

Authors:  Hirohito Sato; Yukio Horikawa; Katsumi Iizuka; Noriko Sakurai; Takeshi Tanaka; Nobuyuki Shihara; Akihiko Oshima; Jun Takeda; Masahiko Mikuni
Journal:  J Neurochem       Date:  2008-05-19       Impact factor: 5.372

Review 4.  The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders.

Authors:  Elisabeth B Binder
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

5.  Stress differentially modulates mRNA expression for corticotrophin-releasing hormone receptors in hypothalamus, hippocampus and pituitary of prairie voles.

Authors:  Hossein Pournajafi-Nazarloo; Leila Partoo; Lisa Sanzenbacher; Jamespaul Paredes; Kozo Hashimoto; Fereidoun Azizi; C Sue Carter
Journal:  Neuropeptides       Date:  2009-01-30       Impact factor: 3.286

6.  Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions.

Authors:  Ville Paakinaho; Harri Makkonen; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Mol Endocrinol       Date:  2010-01-21

7.  Gene expression patterns in brain cortex of three different animal models of depression.

Authors:  L Urigüen; D Arteta; R Díez-Alarcia; M Ferrer-Alcón; A Díaz; A Pazos; J J Meana
Journal:  Genes Brain Behav       Date:  2008-03-21       Impact factor: 3.449

8.  Maternal separation alters nerve growth factor and corticosterone levels but not the DNA methylation status of the exon 1(7) glucocorticoid receptor promoter region.

Authors:  W M U Daniels; L R Fairbairn; G van Tilburg; C R E McEvoy; M J Zigmond; V A Russell; D J Stein
Journal:  Metab Brain Dis       Date:  2009-10-09       Impact factor: 3.584

9.  The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.

Authors:  Magnus Lekman; Gonzalo Laje; Dennis Charney; A John Rush; Alexander F Wilson; Alexa J M Sorant; Robert Lipsky; Stephen R Wisniewski; Husseini Manji; Francis J McMahon; Silvia Paddock
Journal:  Biol Psychiatry       Date:  2008-01-11       Impact factor: 13.382

10.  Family-based association of FKBP5 in bipolar disorder.

Authors:  V L Willour; H Chen; J Toolan; P Belmonte; D J Cutler; F S Goes; P P Zandi; R S Lee; D F MacKinnon; F M Mondimore; B Schweizer; J R DePaulo; E S Gershon; F J McMahon; J B Potash
Journal:  Mol Psychiatry       Date:  2008-01-08       Impact factor: 15.992

View more
  110 in total

Review 1.  Organization and function of the FKBP52 and FKBP51 genes.

Authors:  Donna L Cioffi; Tina R Hubler; Jonathan G Scammell
Journal:  Curr Opin Pharmacol       Date:  2011-04-21       Impact factor: 5.547

2.  Glucocorticoid sensitizers Bag1 and Ppid are regulated by adolescent stress in a sex-dependent manner.

Authors:  Chase H Bourke; Madiha Q Raees; Sanjana Malviya; Cory A Bradburn; Elisabeth B Binder; Gretchen N Neigh
Journal:  Psychoneuroendocrinology       Date:  2012-05-29       Impact factor: 4.905

3.  Developmental and environmental influences on physiology and behavior--2014 Alan N. Epstein Research Award.

Authors:  Kellie L K Tamashiro
Journal:  Physiol Behav       Date:  2015-08-17

Review 4.  Stress and glucocorticoid receptor transcriptional programming in time and space: Implications for the brain-gut axis.

Authors:  J W Wiley; G A Higgins; B D Athey
Journal:  Neurogastroenterol Motil       Date:  2016-01       Impact factor: 3.598

Review 5.  Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications.

Authors:  Anthony S Zannas; Tobias Wiechmann; Nils C Gassen; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2015-08-13       Impact factor: 7.853

6.  Accelerated neurodegeneration through chaperone-mediated oligomerization of tau.

Authors:  Laura J Blair; Bryce A Nordhues; Shannon E Hill; K Matthew Scaglione; John C O'Leary; Sarah N Fontaine; Leonid Breydo; Bo Zhang; Pengfei Li; Li Wang; Carl Cotman; Henry L Paulson; Martin Muschol; Vladimir N Uversky; Torsten Klengel; Elisabeth B Binder; Rakez Kayed; Todd E Golde; Nicole Berchtold; Chad A Dickey
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

7.  Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence.

Authors:  Sophie E Holmes; Matthew J Girgenti; Margaret T Davis; Robert H Pietrzak; Nicole DellaGioia; Nabeel Nabulsi; David Matuskey; Steven Southwick; Ronald S Duman; Richard E Carson; John H Krystal; Irina Esterlis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

8.  DNA methylation and sex-specific expression of FKBP5 as correlates of one-month bedtime cortisol levels in healthy individuals.

Authors:  Richard S Lee; Pamela B Mahon; Peter P Zandi; Mary E McCaul; Xiaoju Yang; Utsav Bali; Gary S Wand
Journal:  Psychoneuroendocrinology       Date:  2018-07-04       Impact factor: 4.905

9.  Reduced DNA methylation of FKBP5 in Cushing's syndrome.

Authors:  Eugenia Resmini; Alicia Santos; Anna Aulinas; Susan M Webb; Yolanda Vives-Gilabert; Olivia Cox; Gary Wand; Richard S Lee
Journal:  Endocrine       Date:  2016-09-23       Impact factor: 3.633

10.  Methylation of the FKBP5 gene in association with FKBP5 genotypes, childhood maltreatment and depression.

Authors:  Johanna Klinger-König; Johannes Hertel; Sandra Van der Auwera; Stefan Frenzel; Liliane Pfeiffer; Melanie Waldenberger; Janine Golchert; Alexander Teumer; Matthias Nauck; Georg Homuth; Henry Völzke; Hans J Grabe
Journal:  Neuropsychopharmacology       Date:  2019-01-23       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.